Credit: Canva
In what is being considered a huge leap in the field of reproductive health, a baby girl has been born to a mother with a donated womb in the UK. Grace Davidson, 36, was born with Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, a rare condition in which the uterus is absent or underdeveloped, but the ovaries function normally. In 2023, she underwent the UK’s first successful womb transplant, receiving the uterus from her sister, Amy Purdie.
Two years after the groundbreaking transplant, Grace gave birth to her daughter, Amy, in February 2025. The name honours the woman who made the pregnancy possible. The new mother described the moment she first held Amy, who weighed just over two kilos (4.5 pounds), as "incredible" and "surreal." "It was quite overwhelming because we'd never really let ourselves imagine what it would be like for her to be here," she said.
Grace first spoke to the BBC in 2018 about her hopes of becoming a mother through a womb transplant. Although her mother was initially considered as a donor, her uterus was found to be unsuitable. By 2019, Grace's sister Amy—already a mother of two—was being evaluated as a donor. After pre-surgery counselling and IVF treatment, Grace had several embryos stored.
The transplant, delayed due to the pandemic, was finally performed in February 2023. A surgical team of over 30 medics took 17 hours to remove Amy’s womb and successfully transplant it into Grace. Within two weeks, Grace experienced her first period and later conceived through IVF on the first attempt.
Grace described feeling her baby's first kick as "incredible" and the entire pregnancy as "really special." Baby Amy was born via Caesarean section at Queen Charlotte’s and Chelsea Hospital on 27 February. "It was an incredible moment, full of joy," said surgeon Isabel Quiroga, who led the transplant team.
The couple hopes to have a second child before the donated womb is removed. This will allow Grace to stop taking immunosuppressant drugs, which prevent organ rejection but can increase cancer risk if taken long-term. Surgeon Quiroga assured that the risk should return to baseline once the uterus is removed.
Professor Richard Smith, a gynaecological surgeon at Imperial College Healthcare and head of Womb Transplant UK, called Amy's birth "astonishing and incredibly moving." He said around 15,000 women in the UK of childbearing age lack a functioning uterus, including about 5,000 born without one. His charity covered NHS costs for Grace’s transplant, with medical professionals donating their time.
Currently, 10 women are in fertility treatment or have embryos stored. Each transplant costs approximately £30,000, and the charity is funding two more. The clinical trial aims to complete 15 transplants—five from living donors and 10 from deceased ones. For Grace, the experience has deepened her bond with her sister. "It was incredibly difficult to let her do that for me," she said. "It's a huge act of sisterly love."
ALSO READ: 3 Ophthalmologist-Approved Ways To Refresh And Relax Your Eyes Once A Week For Strong Vision
Credits: Canva
NHS expanded access of a life-extending prostate cancer drug after a campaign ran by a patient and a charity. This drug is abiraterone, which had been available on the NHS in Scotland and Wales since 2023, but now in England and Northern Ireland, except in the most severe cases.
In the UK, the cancer drug is prescribed for patients with prostate cancer at a very advanced stage. However, now, the drug will be available to prostate cancer patients in England on the NHS, even for those where cancer has not metastasized or spread. This could save hundreds of lives.
The assistant director of health improvement at charity Prostate Cancer UK, Amy Rylance said that the decision was "a momentous, life-saving victory for the thousands of men whose lives will not be saved".
The charity estimated that this will enable 7,000 men a year to start their treatment, with around 1,470 cancers being avoided rom getting worse. This could save somewhere around 560 lives.
The drug is soon to be available on NHS England in weeks.
As per the Cancer Research UK, abiraterone is a hormone therapy drug. The Prostate Cancer UK notes that this is most commonly offered to men whose cancer has stopped responding to other types of cancer drugs.
As per Mayo Clinic, it is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer and metastatic high risk castration-sensitive prostate cancer. This medicine is only available on doctor's prescription and is available as a tablet.
The prostate is a small walnut-shaped gland in men that produces seminal fluid that nourishes and transports sperm. It occurs when abnormal cells form and grow in that gland.
Experts say that not all prostate cancer is deadly. There are cancers that are slow-growing and will not affect a man's lifespan, which is found in 1 in 3 men over 50. Then there is a small number of very aggressive prostate cancers which move quickly and cause harm, this is why regular screening is important.
Read: Olympic Cyclist Sir Chris Hoy Shares His Diagnosis Of Prostate Cancer From A Common Shoulder Pain
In the UK, there is no prostate cancer screening programme like those for breast, bowel and cervical cancer. The onus is therefore on men to request a blood test from their general practitioner once they are over 50. When not aware, it can become life-threatening as it did for Sir Chris Hoy, the six-time Olympic cyclist, who opened up on his diagnosis of the same through a shoulder pain last year.
Despite more men dying from prostate cancer than women from breast cancer, as per BBC, there are no reliable tests for this. The blood test that men over 50 request from their general practitioner measure prostate-specific antigen (PSA), released by the prostate, a small gland located below the bladder involved in the production of semen.
However, experts say that PSA levels can be high for many other reasons too, including enlarged prostate, inflammation, infection, recent vigorous exercise or sex.
Credits: Canva
The latest vaccine recommendation are confusing, children should not be dying because of such ambiguity, say experts. Doctors have noted that the recent vaccine recommendation which removed four vaccines, including influenza vaccine from recommended shots compulsory for children is giving mixed signals. This is at the time when the country has reached record-breaking rates of illness and hospitals are struggling to keep up with the surge of flu patients.
Seema Lakdawala, associate professor of microbiology and immunology at Emory School of Medicine, as reported by The Guardian said, "We are in the midst of a very severe flu season". However, she pointed, despite this, the US has dismantled many of its vaccine recommendation, now the flu vaccine must have a "shared clinical decision-making".
While the secretary of the US Department of Health and Human Services and vaccine critic Robert F Kennedy Jr told CBS News "that's a better thing" upon being asked if these new restrictions would mean fewer children getting vaccination against the flu. However, doctors say otherwise. Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services also said, "Every year, there is a flu vaccine. It does not always work very well. That's why it's been controversial of late". Instead, Oz told Newsmax that Americans must "take care" of themselves, so they can "overwhelm" the flu when they encounter it.
While the Centers for Disease Control and Prevention (CDC)'s press statement reads: "the decision to vaccinate is a personal one”. The press statement has asked people to consult their GPs and doctors and understand the "potential risks and benefits associated with vaccines".
Also Read: Flu Symptoms In Kids Could Be Deadly, Doctors Say Shot Is Still The Best Protection
Megan Berman, professor of internal medicine at the University of Texas Medical Branch, and faculty with the Sealy Institute for Vaccine Sciences told The Guardian, that vaccine rates have already gone down and with these new changes, it will further dampen the vaccination rates because it "gives the message that it is not important". Yet, "nothing has changed from the science, and I know that physicians are still strongly recommending it to everyone six months and older...Children should not be dying from a preventable illness".
Dr. Yvonne Maldonado, a pediatric infectious disease epidemiologist and professor at Stanford University, told TODAY.com, “It’s more than unfortunate; it's tragic," for the CDC to change its flu shot guidance for kids. “(Flu shots) probably are the most effective intervention in the last 100 years to reduce child deaths in this country.”
Experts have warned that the new guidance creates confusion, which could lead to fewer children getting vaccinated. However, doctors time and again have said that the best line of defense remains to be the flu shots. Dr Pedro Piedra, professor of molecular virology and pediatrics at Baylor College of Medicine told Today.com, "There is plenty of data showing the effectiveness... of the influenza vaccine in children." The CDC website also states that the "flu vaccine can prevent severe, life-threatening complications in children."
Credits: Wikimedia Commons and Tylenol
At a press conference in September 2025, President Donald Trump announced of a connection between the use of Tylenol, a popular pain medicine during pregnancy and autism. The active ingredient acetaminophen, while, many studies, have shown does not have any link with childhood autism if consumed during pregnancy. However, Trump insisted that "They", [read the FDA], "are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary...if you cannot tough it out..."
However, a scientific review of 43 studies on acetaminophen use during pregnancy concluded that there was no evidence that the painkiller increased the risk of autism or any other neurodevelopmental disorders.
The lead author of the report, Dr Asma Khalil, professor of obstetrics and maternal fetal medicine at St George's Hospital, University of London, in a news briefing said, "We found no clinically important increase in the risk of autism, ADHD, or intellectual disability." The findings were published on Friday in British medical journal The Lancet.
Dr Khalil said that acetaminophen, which is an active ingredient in Tylenol, remains "the first line treatment that we would recommend if the pregnant women have pain or fever in pregnancy".
Read: Tylenol And Autism: Trump Announces Link Between The Two, Science Does Not Back Him
Earlier studies too, including one of which is published in American Family Physician in 2014 also noted that during pregnancy most people used acetaminophen, sold under the brand name Tylenol. Acetaminophen is considered the one safe over-the-counter option for pain or fever for pregnant people. Other common pain relief options like ibuprofen or regular-dose-aspirin is available, however, they can pose serious risk in pregnancy and could lead to complications.
2024 study published in JAMA Network, titled Acetaminophen Use During Pregnancy and Children’s Risk of Autism, ADHD, and Intellectual Disability, there is no risk of autism for mothers who consume the medicine during pregnancy. The study notes: "Acetaminophen use during pregnancy was not associated with children’s risk of autism, ADHD, or intellectual disability in sibling control analyses."
James Cusack, chief executive of Autistica, a UK autism research and campaigning charity in London, who is autistic told Nature: "There is no definitive evidence to suggest that paracetamol use in mothers is a cause of autism, and when you see any associations, they are very, very small. At the heart of this is people trying to look for simple answers to complex solutions.”
Read More: Trump's Claim On Linking Tylenol And Autism Is Unscientific, According To Doctors
Helen Tager-Flusberg, a psychologist who studies autism at Boston University, Massachusetts told Nature, "he better controlled studies are less likely to find even a small risk. And even then, what we're talking about is a minor association. … We do not think that taking acetaminophen is in any way contributing to actually causing autism.”
A study led by Viktor Ahlqvist, an epidemiologist at the Karolinska Institute in Stockholm (mentioned above, published in JAMA Network) is considered one of the biggest studies in this subject have also found no such link.
Ahlqvist’s team analyzed data from nearly 2.5 million children born in Sweden between 1995 and 2019, drawing from the nation’s detailed health records. These included acetaminophen prescriptions during pregnancy, self-reported use collected by midwives, and later autism diagnoses in children.
The findings showed autism in about 1.42% of children exposed to acetaminophen prenatally, compared to 1.33% among those not exposed, a difference Ahlqvist described as “very small.”
Medical bodies across the world, including the American College of Obstetricians and Gynecologists, were quick to push back against the president’s remarks. They stressed that doctors already advise pregnant women to use acetaminophen carefully and warned that leaving a fever untreated during pregnancy can pose serious risks to both the mother and the baby.
Because acetaminophen can enter the brain and cross the placenta, researchers have been studying its potential impact on fetal brain development for over a decade. However, reaching clear conclusions has proved challenging.
One major reason is the ethical limits on research involving pregnant women. Randomized controlled trials, considered the gold standard in medical science, have not been carried out in this case, making it harder to establish cause-and-effect relationships.
Another complication is how commonly acetaminophen is used. Many other painkillers are known to be harmful during pregnancy, which is why acetaminophen has long been recommended as the safest first option. Its over-the-counter availability also makes it difficult for researchers to accurately track how much is taken, how often, and at what stage of pregnancy.
© 2024 Bennett, Coleman & Company Limited